Canadian Cancer Trials Group Bulletins

General


Recent Publication

Final results of Canadian Cancer Trials Group IND.186 were recently published in the journal Leukemia & Lymphoma.

Macdonald DA, Assouline SE, Brandwein J, Kamel-Reid S, Eisenhauer EA, Couban S, Caplan S, Foo A, Walsh W, Leber B. A Phase I/II Study of Sorafenib (BAY 43-9006) In Combination with Low Dose Cytarabine (LDAC) In Elderly Patients with AML or High-Risk MDS from the Canadian Cancer Trials Group: Trial IND.186 (ONLINE). Leuk Lymphoma 2012.

http://informahealthcare.com/doi/abs/10.3109/10428194.2012.737917